期刊文献+

利塞膦酸钠与羟磷酸盐联合应用治疗绝经后骨质疏松症的实验研究 被引量:1

下载PDF
导出
摘要 目的观察和分析利塞膦酸钠与羟磷酸盐联合应用对绝经后骨质疏松家兔的治疗作用。方法观测利塞膦酸钠及利塞膦酸钠与羟磷酸盐联合应用对实验性绝经后骨质疏松家兔血清碱性磷酸酶活性、血钙、血磷、股骨骨密度及骨小梁宽度的影响。结果与单独使用利塞膦酸钠组相比,利塞膦酸钠与羟磷酸盐联合应用可明显增加绝经后骨质疏松家兔血钙值(P<0.01),血磷值(P<0.05),股骨骨密度及骨小梁宽度的测定与对照组相比差异有统计学意义(P<0.01),血清ALP无明显差异(P>0.05)。结论利塞膦酸钠与羟磷酸盐联合应用对绝经后骨质疏松家兔有明显的治疗作用。
出处 《西北药学杂志》 CAS 2012年第5期474-475,共2页 Northwest Pharmaceutical Journal
  • 相关文献

参考文献9

  • 1Carr A J, Thompson PW, Cooper C. Factors assocated with adherence and persistence to hisphosphonate thera- py in osteoporosis.-a cross-section survey[J]. Osteopo- ros Int, 2006,17 :1638-1644.
  • 2全会标,高勇义.利塞膦酸钠临床研究进展[J].医学综述,2007,13(1):66-68. 被引量:12
  • 3Mori HM Anabe M,Kurach I Y,et al. Osteo integration of dental implants in rabbit bone with low mineral den- sity [J]. J Oral Maxillofae Surg, 1997,55 : 351.
  • 4TrabuIus S,Altiparmak MR,Apaydin S,et al. Treatment of renal transplant recipients with low bone mineral density:a randomized prospective trial of alendronate, alfacalcidol,and alendronate combined with alfacalcidol [J]. Transplant Proc, 2008,40 : 160-166.
  • 5Fujimo to T, Niimi A, Sawai T, et al. Effects of steroid induced osteoporosis on osteointegration of titanium im- plants [J ]. Int J Oral Maxillofac Impl, 1998,13 : 183.
  • 6Glintborg D, Andersen M, Hagen C, et al. Association of pioglitazone treatment with decreased bone mineral den- sity in obese premenopausal patients with polycystic o- vary syndrome: a randomized, placebo-controlled trial [J]. Clin Endocrinol Metab, 2008,93 : 1696-1701.
  • 7Balena R,Kleerekoper M, Foldesj A,et al. Effects of dif- ferent regimens of sodium fluoride treatment for osteo- porosis on the structure, remodeling and mineralization of bone[J]. Osteoporos Int, 1998,8 ( 5 ) : 428-435.
  • 8Reid IR, Cundy T. Addition of monofluorophosphate to estrogen therapy in postmenopausal osteoporosis: aran- domized controlled trial [J]. Clin Endocrinol Metab, 2007,92 : 2246-2252.
  • 9Cao J J, Wronski TJ, Iwaniec U, et al. Aging increases stromal osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse[J]. Bone Miner Res, 2005,20 : 1659-1668.

二级参考文献17

  • 1姚斌,许雯,李建娟,胡国亮,翁建平,梁奕铨,胡少眉.利塞膦酸钠在防治绝经后骨质疏松症中的作用[J].中华全科医师杂志,2004,3(4):241-244. 被引量:3
  • 2潘天荣,王长江,邵宜波,汪延华.二膦酸盐治疗骨质疏松及骨量减少的随机对照研究[J].中国骨质疏松杂志,2005,11(3):356-358. 被引量:3
  • 3Frith JC,Monkkonen J,Auriola S,et al.The molecular mechanism of action of the anteresorptive and antiinflammatory drug clodronate:Evidence for the formation in vivo of a matabolite that inhabits bone resorption and causes osteoclast and macrophage apoptosis[J].Arthritis Rheum,2001,44(9):2201-2210.
  • 4Olmos JM,De Vega T,Perera L,et al.Etidronate inhibits the production of IL-6 by Osteoblast-like cells[J].Methods Find Exp Clin Pharmacol,1999,21(8):519-522.
  • 5Harris ST,Watts NB,Genant HK,et al.Effects of risedronate treatment on vertebral and novertebral fractures in women with postmenopausal osteoporosis:a randomized controlled trial[J].JAMA,1999,282 (14):1344-1352.
  • 6Fogelman I,Ribot C,Smith R,et al.Risedronate reverses bone loss in postmenopausal women with low bone mass:results from a multinational,double-blind,placebo-controlled trial[J].J Clin Endocrinol Metab,2000,85(5):1895-1900.
  • 7Reginster J,Minne HW,Sorensen OH,et al.Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal ostecporosis[J].Osteoporosis Int,2000,11 (1):83-91.
  • 8Mitchell DY,Eusebio RA,sauo Gibson NA,et al.Dose proportional pharmacokinetics of rise dronate on single dose oral administration to healthy volunteers[J].J Clin Pharmacol,2000,40 (3):258-265.
  • 9Mitchell DY,Heise MA,Pallone KA,et al.The effect of dosing regimen on the pharmacokinetics of risedronate[J].Br J Clin Pharmacol,1999,48(4):536-542.
  • 10Mitchell DY,St Peter JV,Eusebio RA,et al.Effect of renal function on risedronate pharmacokinetics after a single oral dose[J].Br J Clin Pharmacol,2000,49(3):215-222.

共引文献11

同被引文献6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部